June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
OCT Biomarkers Associated with Reading Performance in Patients with Neovascular Age-Related Macular Degeneration and Good Visual Acuity
Author Affiliations & Notes
  • Federico Ricardi
    Universita degli Studi di Torino, Torino, Piemonte, Italy
  • Giacomo Boscia
    Universita degli Studi di Bari Aldo Moro, Bari, Puglia, Italy
  • Francesco Gelormini
    Universita degli Studi di Torino, Torino, Piemonte, Italy
  • Valentina Marica
    Universita degli Studi di Torino, Torino, Piemonte, Italy
  • Fabio Conte
    Universita degli Studi di Torino, Torino, Piemonte, Italy
  • Francesco Bandello
    Universita Vita Salute San Raffaele, Milano, Lombardia, Italy
  • Enrico Borrelli
    Universita Vita Salute San Raffaele, Milano, Lombardia, Italy
  • Michele Reibaldi
    Universita degli Studi di Torino, Torino, Piemonte, Italy
  • Footnotes
    Commercial Relationships   Federico Ricardi None; Giacomo Boscia None; Francesco Gelormini None; Valentina Marica None; Fabio Conte None; Francesco Bandello None; Enrico Borrelli None; Michele Reibaldi None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 321. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Federico Ricardi, Giacomo Boscia, Francesco Gelormini, Valentina Marica, Fabio Conte, Francesco Bandello, Enrico Borrelli, Michele Reibaldi; OCT Biomarkers Associated with Reading Performance in Patients with Neovascular Age-Related Macular Degeneration and Good Visual Acuity. Invest. Ophthalmol. Vis. Sci. 2023;64(8):321.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Even in presence of a good distance visual acuity, patients with neovascular age-related macular degeneration (AMD) may complain of near vision impairment and reduced reading ability with a significant impact on their quality of life. The aim of this study was to evaluate reading performance metrics in neovascular AMD patients with high values of distance visual acuity and to investigate their association with retinal structural biomarkers

Methods : We prospectively enrolled 90 patients with previously-treated exudative neovascular AMD and best-corrected visual acuity (BCVA) ≤ 0.3 LogMAR. The reading acuity score (RA score) and maximal reading speed (max RS) metrics were tested using the Radner Reading Chart (RRC). Two experienced readers graded different optical coherence tomography (OCT) findings associated with exudative neovascular AMD within each Early Treatment Diabetic Retinopathy Study (ETDRS) subfield. A regularized linear model with the least absolute shrinkage and selection operator (LASSO) was used to evaluate the association of these biomarkers with reading performance metrics.

Results : A total of 90 eyes from 90 patients were included in this study (median [IQR] age 81.0 [75.0-84.0] years; median [IQR] BCVA, 0.1 [0.05-0.22] LogMAR). Reading performance was characterized by a median (IQR) monocular RA score of 0.54 (0.42-0.63) logarithm of the reading acuity determination (LogRAD) and a mean (±SD) monocular max RS of 137.6 (±47.3) words per minute (wpm).
In the multivariable cross-sectional analysis, syllables mispronounced or unread, ellipsoid zone disruption in the outer lower ETDRS subfield, external limiting membrane disruption in the central ETDRS subfield, age, and BCVA showed an association with RA score (cross-validated R2 for RA score of 0.23). Variables that showed an association with max RS were ellipsoid zone disruption in the inner lower ETDRS subfield, RPE loss in the inner left ETDRS subfield, external limiting membrane disruption in the inner left ETDRS subfield, age, and BCVA (cross-validated R2 for max RS of 0.23)

Conclusions : OCT biomarkers reflecting outer retinal damage are associated with worse reading performance in patients with neovascular AMD and good visual acuity. Our findings may suggest that metrics reflecting the reading performance may be considered as novel relevant functional endpoints in clinical trials

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×